Key takeaways
Joint pain isn’t a labeled side effect in the prescribing information for tirzepatide, but musculoskeletal complaints have been reported by people taking the medication.
Rapid weight loss can lead to muscle loss and joint instability, which may contribute to joint and muscle discomfort in people taking tirzepatide.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Joint pain isn’t a labeled side effect in the prescribing information for tirzepatide, but musculoskeletal complaints have been reported by people taking the medication.
Rapid weight loss can lead to muscle loss and joint instability, which may contribute to joint and muscle discomfort in people taking tirzepatide.
If you’re taking tirzepatide (Zepbound, Mounjaro) and notice some soreness or body aches, you may be wondering: Can tirzepatide cause joint pain?
The short answer: Joint pain isn’t listed as a direct side effect in the prescribing information for tirzepatide. But that doesn't mean it can't happen. There are several indirect ways in which tirzepatide may contribute to joint and muscle discomfort. Most of them are tied to how the body responds to rapid weight loss.
This article breaks down what the evidence says about tirzepatide joint pain, what to watch out for, and what you can do to feel better.
Can tirzepatide cause joint pain?
Tirzepatide isn’t labeled as a cause of joint pain in the US Food and Drug Administration (FDA)’s prescribing information for the drug. But these types of complaints have been reported to the FDA's Adverse Events Reporting System (FAERS).
Between 2022 and 2024, muscle and tissue-related adverse side effects associated with tirzepatide increased year over year. Reports rose from 67 in 2022 to 279 in 2024.
While this rise tracks with the growing use of the medication, FAERS reports alone don’t confirm that tirzepatide directly caused these side effects.
For people asking, “does Mounjaro cause body aches?”, evidence suggests that when joint pain does occur, it may be linked to the indirect effects of rapid weight loss including muscle loss and reduced musculoskeletal support.
Why tirzepatide may cause joint pain and body aches
There are several reasons why people taking tirzepatide may experience joint pain, muscle aches, or body stiffness. Some may be linked to the indirect effects of rapid weight loss, such as muscle loss and joint instability.
In rarer cases, early case evidence suggests tirzepatide may directly affect muscle tissue, as GLP-1 receptors are found in skeletal muscle and may play a role in muscle cell function.
Rapid weight loss and biomechanical changes
Rapid weight loss changes how the musculoskeletal system supports the body.
While weight loss generally reduces joint loading and can improve joint pain, it may also lead to some loss of muscle mass and, in some cases, reduced bone density. These changes can temporarily contribute to discomfort, stiffness, or soreness as the body adjusts.
Muscle loss without resistance training
When people lose weight on medications like tirzepatide, some loss of lean body mass can happen along with fat loss. Research shows that up to 25% of total weight lost on tirzepatide can come from lean body mass (which is composed of muscle, water, connective tissue, and non-fat tissues).
This is why it’s important to preserve muscle mass. You can do this by combining resistance training with other forms of movement, such as walking or other aerobic activities.
Getting enough protein is important, too, but it works best when paired with resistance training. This helps support muscle preservation during weight loss.
Dehydration (indirectly)
Tirzepatide may cause side effects like diarrhea and vomiting that can lead to dehydration. Hydration plays an important role in how cartilage behaves inside the joints.
Research shows that changes in cartilage water content can affect its response to stress and movement. When cartilage becomes less hydrated, its ability to absorb and dissipate forces changes. This may influence how joints feel during activity.
That being said, these studies were conducted on tissue samples and not in actual people. So while it’s possible that dehydration associated with tirzepatide side effects could contribute to joint discomfort, there isn’t enough research to say whether this truly happens in humans.
GLP-1 receptors and inflammatory pathways
Tirzepatide is a dual GLP-1/GIP receptor agonist and activates GLP-1 receptors, which are found in joint tissues like cartilage and the synovial membrane (the lining inside joints).
Some preclinical research suggests that GLP-1 receptor activation may have anti-inflammatory effects on joint tissue and may reduce cartilage breakdown. Whether this translates into joint pain relief or discomfort in real-world tirzepatide users needs to be studied further.
Does tirzepatide joint pain go away?
Some people report that joint pain does go away. As the body adjusts, these aches can start to ease. That said, everyone’s experience is a little different. For some, improvement can be quick, while for others it can take a bit longer.
If the pain sticks around, gets worse, or starts to interfere with daily life, it’s a good idea to check in with a healthcare provider. They can help figure out what’s going on and whether your symptoms are truly related to tirzepatide or there’s an alternative explanation for your symptoms.
When to contact a healthcare provider
Most muscle soreness or joint stiffness on tirzepatide is mild and manageable, but some symptoms may signal something more serious. Contact a healthcare provider promptly if you experience any of the following:
Severe muscle pain
Dark or tea-colored urine
Muscle weakness
Muscle swelling, stiffness, or tenderness
Reduced urine output
These may be signs of a condition that needs medical evaluation.
How to manage joint pain and body aches on tirzepatide
Several practical steps may help reduce musculoskeletal discomfort while on tirzepatide.
Try low-impact aerobic exercise: Low-impact activities like walking or cycling may help support joint function and reduce discomfort. Research suggests aerobic exercise can improve functional ability and reduce pain in people with joint conditions.
Prioritize protein intake: Research suggests that increasing daily protein intake can support gains in lean body mass and muscle strength. The recommended amount of protein is around 1.2–1.6 grams/kg of body weight per day for those looking to lose weight. You may even aim for more, depending on your goals.
For example, people prioritizing muscle building or maximal lean mass retention during weight loss may benefit from up to 2 grams of protein per kg of body weight each day. A healthcare provider or registered dietitian can help personalize this to what’s best for you. (You can also give our free protein calculator a go.)
Find your recommended protein intake
Calculate your recommended daily protein needs for weight loss, maintaining weight, or building muscle, based on your current weight and activity level.
Recommended protein intake
0 – 0
Grams/Day
0 – 0
Grams/Meal
This calculator provides general estimates and should not replace professional medical advice. Always consult a healthcare provider or registered dietitian before making significant changes to your diet or nutrition plan.
Incorporate resistance training: Resistance training plays an important role in maintaining muscle mass. Studies show that combining GLP-1 therapies with structured exercise helps preserve lean mass.
Focus on anti-inflammatory foods: A diet rich in fruits, vegetables, whole grains, and healthy fats may help reduce inflammation linked to joint pain. Research suggests that higher consumption of fruits, cereals, and fish is associated with a lower risk of joint conditions.
Stay consistent to avoid weight cycling: Repeated cycles of weight loss and regain can lead to cumulative muscle loss and reduced strength over time. Maintaining a steady, sustainable approach to weight loss may help protect muscle and overall physical function.
Stay well hydrated: Daily fluid needs vary based on sex, body size, activity level, and climate. As a general guide, aim for about 2–3 liters of fluid (~½–¾ gallon) per day.
If you're experiencing tirzepatide muscle aches or Wegovy joint pain, a Ro provider can help. As part of the Ro Body membership, Ro providers are available around the clock to discuss tirzepatide side effects and help you find the right approach.
Bottom line
So, can tirzepatide cause joint pain? Joint pain and body aches aren’t listed as direct side effects in the drug’s prescribing information, but they can still happen. Here is what to keep in mind:
Weight loss side effects: Mounjaro joint pain and body aches may be linked to the indirect effects of rapid weight loss, such as muscle loss and joint instability. As the body adjusts to a new weight and lower muscle mass, joints and muscles may feel sore or stiff for a period of time.
Preserving muscle mass: You may lose muscle mass during weight loss. Resistance training and adequate protein intake can help preserve muscle to keep your joints healthy.
When to act: Rhabdomyolysis is rare but serious. Severe muscle pain, sudden weakness, or dark-colored urine should always prompt a call to a healthcare provider right away.
Overall, most people taking tirzepatide don’t experience severe musculoskeletal side effects. For those who do, symptoms may improve with time (as is the case with common tirzepatide side effects).
And if Zepbound or Mounjaro body aches or tirzepatide joint pain are affecting your daily life, a healthcare provider can help find the right approach for you.
Frequently asked questions (FAQs)
Does tirzepatide cause body pain?
Yes, tirzepatide may cause body pain in some people, but it’s not a labeled side effect in the prescribing information. Research in people with osteoarthritis suggests that body aches and muscle soreness may be linked to the indirect effects of rapid weight loss, like muscle loss and joint instability.
In rare cases, tirzepatide may directly affect muscle tissue. If pain is severe or persistent, contact a healthcare provider.
Are achy joints a side effect of Mounjaro?
No, achy joints aren’t a confirmed side effect of Mounjaro. Some people taking Mounjaro do report musculoskeletal discomfort. But it’s not officially recognized as a common adverse reaction in clinical trial data.
Is arthritis a side effect of tirzepatide?
No, arthritis isn’t a recognized side effect of tirzepatide. However, rapid weight loss may affect joint stability and muscle mass, which can be a consideration for people who already have conditions like osteoarthritis.
If your joint pain is significant, a healthcare provider can assess whether an underlying condition is involved.
How long does joint pain last on tirzepatide?
There’s no set timeline for how long joint pain lasts on tirzepatide. As the pace of weight loss slows and the body adjusts, some people find that aches improve. Pain that’s worsening, severe, or affecting your daily functioning should be evaluated by a healthcare provider.
What can I do to reduce body aches on tirzepatide?
Should I stop tirzepatide if I have joint pain?
No, if you have joint pain, you should not stop taking tirzepatide without first consulting a healthcare provider. They can help you determine if your joint pain is truly caused by the medication or if it may be due to other common causes, such as osteoarthritis.
Can rhabdomyolysis happen on tirzepatide?
Yes. While rhabdomyolysis isn’t a known common side effect of tirzepatide, it may occur in rare cases, usually when other risk factors are present. If you develop severe muscle pain, weakness, or dark urine, get medical care right away.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
References
Carbone, J. W. & Pasiakos, S. M. (2019). Dietary Protein and Muscle Mass: Translating Science to Application and Health Benefit. Nutrients, 11(5), 1136. doi: 10.3390/nu11051136. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6566799/
Crolla, J. P., Lawless, B. M., Cederlund, A. A., et al. (2022). Analysis of hydration and subchondral bone density on the viscoelastic properties of bovine articular cartilage. BMC Musculoskeletal Disorders, 23(1), 228. doi: 10.1186/s12891-022-05169-0. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8905800/
Gatto, A., Liu, K., Milan, N., et al. (2025). The effects of GLP-1 agonists on musculoskeletal health and orthopedic care. Current Reviews in Musculoskeletal Medicine, 18, 469–480. doi: 10.1007/s12178-025-09978-3. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12325148/
Georgiev, T. & Kabakchieva, P. (2025). Weight Loss, but Not at Any Cost: Risks and Challenges in Patients with Osteoarthritis. Mediterranean Journal of Rheumatology, 36(1), 28-35. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12183455/
Hidalgo Ramos, R. A., Hong, I., Ortiz, M., et al. (2025). Effects of Tirzepatide on Skeletal Muscle Mass in Adults: A Systematic Review. Cureus, 17(7), e89020. doi: 10.7759/cureus.89020. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12394919/
Martins, C., Gower, B., & Hunter, G. R. (2022). Metabolic adaptation after combined resistance and aerobic exercise training in older women. Obesity (Silver Spring, Md.), 30(7), 1453–1461. doi: 10.1002/oby.23450. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9256770/
Meinders, A. J. & Meinders, A. E. (2010). Hoeveel water moeten we eigenlijk drinken? [How much water do we really need to drink?]. Nederlands tijdschrift voor geneeskunde, 154, A1757. Retrieved from https://pubmed.ncbi.nlm.nih.gov/20356431/
Nguyen, S., Kaufman, M., Shetty, M., et al. (2025). Lifestyle Interventions and Supplements for Joint and Arthritis Pain: A Narrative Review. American Journal of Lifestyle Medicine, 15598276251395980. Advance online publication. doi: 10.1177/15598276251395980. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12618219/
Noronha, J. C., Van Gaal, L. F., Neeland, I. J., et al. (2025). Optimizing GLP-1 therapies for obesity and diabetes management. Obesity Pillars, 16, 100222. doi: 10.1016/j.obpill.2025.100222. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12661421/
Nunes, E. A., Colenso-Semple, L., McKellar, S. R., et al. (2022). Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults. Journal of Cachexia, Sarcopenia and Muscle, 13(2), 795–810. doi: 10.1002/jcsm.12922. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8978023/
Reddit. (2023). Sore muscles & joint pains. Retrieved from https://www.reddit.com/r/Mounjaro/comments/181zbiw/sore_muscles_joint_pains/
Sonavane, K., Shirsat, P., Agrawal, G., et al. (2025). Rhabdomyolysis associated with the use of tirzepatide. European Journal of Case Reports in Internal Medicine, 12(5), 005392. doi: 10.12890/2025_005392. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12061213
Stanley, M., Chippa, V., Aeddula, N. R., et al. (2022). Rhabdomyolysis. StatPearls. Retrieved on Apr. 1, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK448168/
U.S. Food and Drug Administration (FDA). (2026). Highlights of prescribing information: Mounjaro (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866s009lbl.pdf
U.S. Food and Drug Administration (FDA). (2025). Highlights of prescribing information: Zepbound (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf














